Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass
- PMID: 16998370
- PMCID: PMC1856567
- DOI: 10.1097/01.sla.0000239086.30518.2a
Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass
Abstract
Objectives: Although weight loss following Roux-en-Y gastric bypass is acceptable in patients with preoperative body mass index (BMI) between 35 and 50 kg/m, results from several series demonstrate that failure rates approach 40% when BMI is > or =50 kg/m. Here we report the first large single institution series directly comparing weight-loss outcomes in super-obese patients following biliopancreatic diversion with duodenal switch (DS) and Roux-en-Y Gastric Bypass (RYGB).
Methods: All super-obese patients (BMI > or =50 kg/m) undergoing standardized laparoscopic and open DS and RYGB between August 2002 and October 2005 were identified from a prospective database. Two-sample t tests were used to compare weight loss, decrease in BMI, and percentage of excess body weight loss (% EBWL) after surgery. chi analysis was used to determine the rate of successful weight loss, defined as achieving at least 50% loss of excess body weight.
Results: A total of 350 super-obese patients underwent DS (n = 198) or RYGB (n = 152) with equal 30-day mortality (DS,1 of 198; RYGB, 0 of 152; P = not significant). The % EBWL at follow-up was greater for DS than RY (12 months, 64.1% vs. 55.9%; 18 months, 71. 9% vs. 62.8%; 24 months, 71.6% vs. 60.1%; 36 months, 68.9% vs. 54.9%; P < 0.05). Total weight loss and decrease in BMI were also statistically greater for the DS (data not shown). Importantly, the likelihood of successful weight loss (EBWL >50%) was significantly greater in patients following DS (12 months, 83.9% vs. 70.4%; 18 months, 90.3% vs. 75.9%; 36 months, 84.2% vs. 59.3%; P < 0.05).
Conclusions: Direct comparison of DS to RYGB demonstrates superior weight loss outcomes for DS.
Figures




Comment in
-
Is biliopancreatic diversion with duodenal switch the best surgical treatment for super-obese patients?Nat Clin Pract Gastroenterol Hepatol. 2007 May;4(5):250-1. doi: 10.1038/ncpgasthep0791. Nat Clin Pract Gastroenterol Hepatol. 2007. PMID: 17406373 No abstract available.
Similar articles
-
Laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with duodenal switch or a Roux-en-Y gastric bypass due to weight loss failure: our algorithm.Surg Obes Relat Dis. 2015 Jan-Feb;11(1):79-85. doi: 10.1016/j.soard.2014.04.012. Epub 2014 Apr 24. Surg Obes Relat Dis. 2015. PMID: 25304833
-
One-stage conversion of Roux-en-Y gastric bypass to a modified biliopancreatic diversion with duodenal switch using a hybrid sleeve concept.Surg Obes Relat Dis. 2016 Nov;12(9):1671-1678. doi: 10.1016/j.soard.2016.02.015. Epub 2016 Feb 23. Surg Obes Relat Dis. 2016. PMID: 27260654
-
Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.J Gastrointest Surg. 2010 Feb;14(2):211-20. doi: 10.1007/s11605-009-1101-6. J Gastrointest Surg. 2010. PMID: 19937190
-
Roux-en-Y gastric bypass versus duodenal switch in patients with body mass index ≥50 kg/m2: a systematic review and meta-analysis.Surg Obes Relat Dis. 2025 Feb;21(2):184-193. doi: 10.1016/j.soard.2024.08.042. Epub 2024 Sep 16. Surg Obes Relat Dis. 2025. PMID: 39395846
-
Revision procedures after initial Roux-en-Y gastric bypass, treatment of weight regain: a systematic review and meta-analysis.Updates Surg. 2021 Apr;73(2):663-678. doi: 10.1007/s13304-020-00961-w. Epub 2021 Jan 11. Updates Surg. 2021. PMID: 33428184
Cited by
-
Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes.J Gastrointest Surg. 2008 Feb;12(2):250-5. doi: 10.1007/s11605-007-0427-1. Epub 2007 Dec 11. J Gastrointest Surg. 2008. PMID: 18071836
-
Minimally invasive versus open duodenal switch: a nationwide retrospective analysis.Surg Endosc. 2022 Sep;36(9):7000-7007. doi: 10.1007/s00464-022-09020-4. Epub 2022 Jan 20. Surg Endosc. 2022. PMID: 35059837
-
Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients.Obes Surg. 2008 Sep;18(9):1126-9. doi: 10.1007/s11695-008-9574-z. Epub 2008 Jun 25. Obes Surg. 2008. PMID: 18575943
-
Morbidity, mortality, and weight loss outcomes after reoperative bariatric surgery in the USA.J Gastrointest Surg. 2015 Jan;19(1):171-8; discussion 178-9. doi: 10.1007/s11605-014-2639-5. Epub 2014 Sep 4. J Gastrointest Surg. 2015. PMID: 25186073
-
Gastric Bypass and Influence on Improvement of NAFLD.Curr Gastroenterol Rep. 2017 Jun;19(6):25. doi: 10.1007/s11894-017-0567-8. Curr Gastroenterol Rep. 2017. PMID: 28429199 Review.
References
-
- Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727. - PubMed
-
- Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555. - PubMed
-
- Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–559. - PubMed
-
- National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–961. - PubMed
-
- Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials